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(Correspondence should be addressed to N T Joseph; Email: nerine.joseph@bbsrc.ac.uk)AbstractTwo GnRH isoforms (cGnRH-I and GnRH-II) and two
GnRH receptor subtypes (cGnRH-R-I and cGnRH-R-III)
occur in chickens. Differential roles for these molecules in
regulating gonadotrophin secretion or other functions are
unclear. To investigate this we cloned cGnRH-R-III from a
broiler chicken and compared its structure, expression and
pharmacological properties with cGnRH-R-I. The broiler
cGnRH-R-III cDNA was 100% identical to the sequence
reported in the red jungle fowl and white leghorn breed.
Pituitary cGnRH-R-III mRNA was w1400-fold more
abundant than cGnRH-R-I mRNA. Northern analysis
indicated a single cGnRH-R-III transcript. A pronounced
sex and age difference existed, with higher pituitary transcript
levels in sexually mature females versus juvenile females. In
contrast, higher expression levels occurred in juvenile males
versus sexually mature males. Functional studies in COS-7Journal of Endocrinology (2009) 202, 179–190
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distribution, and reproduction in any medium, provided the original work is propcells indicated that cGnRH-R-III has a higher binding
affinity for GnRH-II than cGnRH-I (Kd: 0.57 vs 19.8 nM)
with more potent stimulation of inositol phosphate pro-
duction (ED50: 0.8 vs 4.38 nM). Similar results were found
for cGnRH-R-I, (Kd: 0.51 vs 10.8 nM) and (ED50: 0.7 vs
2.8 nM). The initial rate of internalisation was faster for
cGnRH-R-III than cGnRH-R-I (26 vs 15.8%/min). Effects
of GnRH antagonists were compared at the two receptors.
Antagonist #27 distinguished between cGnRH-R-I and
cGnRH-R-III (IC50: 2.3 vs 351 nM). These results suggest
that cGnRH-R-III is probably the major mediator of
pituitary gonadotroph function, that antagonist #27 may
allow delineation of receptor subtype function in vitro and
in vivo and that tissue-specific recruitment of cGnRH-R
isoforms has occurred during evolution.
Journal of Endocrinology (2009) 202, 179–190Introduction
The hypothalamic decapeptide GnRH is a central regulator of
reproductive function in vertebrates (Millar 2005). Two
GnRH isoforms are present in the chicken; cGnRH-I and
GnRH-II (Sharp & Ciccone 2005). There is no genomic
DNA evidence for a third GnRH ligand in the chicken to
date. Both cGnRH-I and GnRH-II stimulate LH release
from chicken pituitary in vitro (Hattori et al. 1986, Millar
et al. 1986) and in vivo (Chou et al. 1985, Hattori et al. 1986,
Sharp et al. 1986, Proudman et al. 2006). LH secretion in
response to GnRH-II is markedly greater than that to
cGnRH-I in mature laying hens. However, this is not the
case in juvenile chickens of either sex, nor the cockerel
(Sharp et al. 1987).
There is conflicting evidence for an effect of cGnRH-I
or GnRH-II on FSH in vitro (Hattori et al. 1986, Millar
et al. 1986), and in vivo (Krishnan et al. 1993, Bruggemanet al. 1998, Dunn et al. 2003, Proudman et al. 2006).
Probably, cGnRH-I does not directly stimulate FSH release,
but may stimulate FSH biosynthesis, while a role of
GnRH-II in FSH production has not been established
(Dunn et al. 2003, Sharp & Ciccone 2005).
Immunisation of laying hens against cGnRH-I, but not
against GnRH-II, results in a complete regression of the
reproductive system and a decrease in plasma LH
(Sharp et al. 1990), suggesting that gonadotrophin secretion
is controlled by cGnRH-I rather than GnRH-II. This
is consistent with the presence of cGnRH-I in the median
eminence (Mikami et al. 1988, Sharp et al. 1990) and the
correlation between hypothalamic cGnRH-I peptide
content and reproductive status (Sharp et al. 1990).
In contrast, abundant levels of GnRH-II (Mikami et al.
1988, Sharp et al. 1990, Vangils et al. 1993) are not
observed in the median eminence and no change in
hypothalamic GnRH-II peptide content is seen in cockerelsDOI: 10.1677/JOE-08-0544
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hypothalamic GnRH-II levels do decrease when the
preovulatory release of LH is maximal or declining in the
hen. Thus, GnRH-II may be involved in neuroendocrine
events preceding ovulation (Wilson et al. 1990). In other
avian species GnRH-II affects reproductive behaviour in
ring doves and female soliciting behaviour in song sparrows
(King & Millar 1995, Maney et al. 1997).
The specific receptor types through which the GnRH
ligands elicit biological responses in the chicken are not
known. GnRH systems exhibit species-specific recruitment
of receptor subtypes and ligands within different tissues. For
example, the sea bass expresses five isoforms of GnRH
receptor and all but one are expressed in the pituitary
(Moncaut et al. 2005). In goldfish, two subtypes of the GnRH
receptor have been identified (Illing et al. 1999) and they are
both expressed in the pituitary. In the bullfrog, three subtypes
of GnRH receptor are expressed but only one predominates
in the pituitary (Wang et al. 2001). Two subtypes of GnRH
receptor occur in the African clawed frog (Xenopus laevis;
Troskie et al. 2000) whereas the leopard gecko expresses three
receptor subtypes in the pituitary, with one receptor subtype
predominating in the anterior pituitary (Ikemoto & Park
2007). The pituitary-specific GnRH receptor subtypes
expressed in the bullfrog (Wang et al. 2001), African clawed
frog (Troskie et al. 2000) and leopard gecko (Ikemoto & Park
2007) differ structurally, according to the nomenclature
proposed by Miller et al. and phylogenetically (Millar
et al. 2004, Flanagan et al. 2007, Tello et al. 2008).
The predominant pituitary GnRH receptor subtype
expressed in the bullfrog is type III, the African clawed frog
is type I and the leopard gecko is type III. This suggests
plasticity in evolutionary recruitment of GnRH receptor
subtypes for regulation of pituitary gonadotrophin pro-
duction. There is also plasticity in the spatiotemporal
expression patterns of GnRH receptor subtypes (Illing
et al. 1999, Troskie et al. 2000, Wang et al. 2001, Moncaut
et al. 2005, Ikemoto & Park 2007).
The promiscuity of receptor subtype activation by different
endogenous GnRH ligands (Illing et al. 1999, Troskie et al.
2000, Wang et al. 2001, Moncaut et al. 2005, Ikemoto & Park
2007) suggests that a complex interplay between ligands and
receptors may occur. The organisation of the avian GnRH
system is distinct from those of teleosts, amphibians, reptiles or
mammals (Ensemble database), having two receptor subtypes
for two GnRH ligands (Morgan & Millar 2004). Further
characterisation of the avian GnRH system may therefore
provide unique information to enable further comprehension
of the interplay between GnRH ligands and their receptors in
the control of reproduction.
The first chicken GnRH-R isoform to be cloned, cGnRH-
R-I is widely expressed (Sun et al. 2001a,b) and GnRH-II has a
higher binding affinity and is more potent in stimulating
inositol phosphate accumulation than cGnRH-I at this
receptor (Sun et al. 2001b). This suggested that the chicken
pituitary might contain an alternative GnRH receptor moreJournal of Endocrinology (2009) 202, 179–190selective for cGnRH-I, since this appears to be the GnRH
isoform most likely to be biologically important for regulation
of LH production. A novel isoform of cGnRH-R was
subsequently cloned by ourselves and others ( Joseph et al.
2006, Shimizu & Bedecarrats 2006; Genbank AY895154).
The white Leghorn isoform of the novel receptor was
designated cGNRHR2 (Shimizu & Bedecarrats 2006), but
it can be classified as a type III GnRH receptor. Using PCR,
this receptor showed expression of two pituitary-specific
transcripts (1260 bp full length and 1065 bp splice variant;
Shimizu & Bedecarrats 2006), in addition to another 501 bp
splice variant that is expressed in different brain regions
(Shimizu & Bedecarrats 2006). Inositol phosphate accumu-
lation in response to GnRH-II stimulation was more potent at
cGNRHR2 (Shimizu & Bedecarrats 2006) than the response
to cGnRH-I. Pituitary cGNRHR2 mRNA expression levels
correlated with reproductive status, suggesting that
cGNRHR2 plays a role in the regulation of gonadotroph
function (Shimizu & Bedecarrats 2006).
The aims of this study were to undertake further
characterisation of this second GnRH receptor isoform
from a broiler chicken (commercial meat-type chicken) and
compare it with the type I receptor. Using bioinformatics
analysis, we confirm that cGNRHR2 is a chicken type III
GnRH receptor homologue. Critically, we have established
the preponderance of cGNRHR2 mRNA relative to
cGnRH-R-I mRNA in the pituitary and expression was
investigated during sexual development and the levels were
quantified in a panel of tissues. We also performed ligand
induced internalisation studies of both receptors and a
detailed pharmacological analysis of the two receptors. This
included analysis of ligand binding and inositol phosphate
production in response to cGnRH-I and GnRH-II and an
array of analogues and antagonists in order to identify a
GnRH analogue that may be applied to examine receptor-
specific effects on gonadotrophin production.Materials and Methods
Animals
Birds were killed in accordance with UK Home Office
guidelines. Tissues were dissected, snap frozen in liquid
nitrogen and stored at K70 8C.
Peptides/primers
GnRH analogues, cGnRH-I, GnRH-II and sGnRH-III
(Sigma–Aldrich) and mammalian antagonists 27, 135-25
and 135-18 were diluted in 20% propylene glycol
(Sigma–Aldrich). Sequences are presented in Table 1.
[His5-D-Tyr6]-GnRH peptide was synthesised with solid-
phase methodology and purified by reverse-phase HPLC
(Flanagan et al. 1998). Oligonucleotides (Sigma–Aldrich)
diluted to 100 pM/ml were used for PCR amplification
and probe synthesis.www.endocrinology-journals.org
Table 1 Primary structure of GnRH analogues
Position of amino acid
1 2 3 4 5 6 7 8 9 10
Peptide name
GnRH-II pGlu His Trp Ser His Gly Trp Tyr Pro Gly NH2
cGnRH-I pGlu His Trp Ser Tyr Gly Leu Gln Pro Gly NH2
His5-D-Tyr6 GnRH pGlu His Trp Ser His D-Tyr Leu Arg Pro Gly NH2
sGnRH-III pGlu His Trp Ser Tyr Gly Trp Leu Pro Gly NH2
27 Ac-D Nal(2)a D-a-Me-4-Cl-Phe D-Trp Ser Ipr-Lys D-Tyr Leu Arg Pro D-Ala NH2
135-18 Ac-D-Nal(2) D-4-Cl-Phe D-Pal(3) Ser Ile D-Ipr-Lys Leu Ipr-Lys Pro D-Ala NH2
135-25 Ac-D-Nal(2) D-4-Cl-Phe D-Pal(3) Ser 1-MePal D-Ipr-Lys Leu Ipr-Lys Pro D-Ala NH2
aAbbreviations for synthetic amino acids are: Nal(2), 3-(2-naphthyl) alanine; 4-Cl-Phe, 3-(4-chlorophenyl) alanine; a-Me-4-Cl-Phe, 2-methyl-3-(-chlorophenyl)
alanine; Ipr-Lys, N3-isopropyllysine.
Chicken type III GnRH receptor . N T JOSEPH and others 181Cloning of cGNRHR2 cDNA
Trizol (Invitrogen) was used to isolate total RNA from
pooled mature male and female anterior pituitary glands
from broilers. cDNA synthesis was performed with 5 mg
total RNA using a first strand synthesis kit (Amersham
Pharmacia Biotech Ltd). Genbank AY895154 was used as
a reference for design of cDNA primers. Primers
1210f (5 0-TGAGTGGGCGGTGTTTGA-3 0) and 3217r
(5 0-TAGAGGCATTGTGGAGCAGA-3 0) encompassing
the entire coding region of the receptor were used for PCR
amplification of pituitary cDNA (35 cycles of 95 8C/30 s,
61.9 8C/30 s, 72 8C/90 s). The product was cloned into
Bluescript II SK(C) vector (Stratagene, The Netherlands) at
the EcoRV site. The entire cDNA insert was sequenced. To
make an expression construct, the fragment between the
BamHI and HincII restriction sites of the Bluescript II SK(C)
construct was removed and subcloned into the pCDNA3.1/
myc-His-A (Invitrogen) mammalian expression vector
between the BamHI and EcoRV sites. The DNA sequence
of the expression construct was verified by BamHI, BsmI and
PstI restriction digest and sequencing.
An expression construct containing cGnRH-R-I cDNA
cloned into pcDNA1/Amp (Invitrogen) eukaryotic
expression vector was used (Sun et al. 2001b) in parallel
studies.Oligonucleotide probes
5 0 end labelling using [g-32P]-dATP and T4 polynucle-
otide kinase was performed with 20 pmol sense
(5 0-TGGTGCCGATGTGGGAGCGCTGGGAGCAGTG-
AGTGGGCGGTGTT TGA-3 0) and anti-sense (5 0-TCAA-
ACACCGCCCACTCACTGCTCCCAGCGCTCCCAC-
AT CGGCACCA-3 0) oligonucleotides using the mirVana
Probe and Marker Kit (Ambion, USA). These oligonucleo-
tides, designed in the 5 0 region upstream of the translation
start site in exon 1 are specific for cGNRHR2 and are not
homologous to cGnRH-R-I.www.endocrinology-journals.orgDNA probes
An actin alpha-1 skeletal muscle (ACTA1; Genbank
001031063) DNA probe was synthesised from 0.25 mg
purified insert DNA by random primer labelling with
32P-dCTP using a Rediprime Kit (GE Healthcare, UK) and
purified using Sephadex G50 Nick columns (GE Healthcare).Riboprobes
A riboprobe was synthesised by in vitro transcription of 1 mg of
the cGNRHR2 construct linearised with EcoRI using the
T7 promoter and a kit (Promega) with [32P]UTP (800 Ci/
mmol, Amersham; specific activity of 30 TBq/mmol).
Free nucleotides were removed using a Sephadex G50
column (GE Healthcare).Northern blot analysis
Ultraspec II (AMS Biotechnology Ltd, UK) was used to isolate
total RNA from ten 14-week-old males of an advanced
intercross of broiler and layer strain population. Poly(A)C
RNA was purified from anterior pituitary gland, testes and
small intestine total RNA using Oligotex mRNA Spin-
Columns (Qiagen). Three micrograms poly(A)C RNA were
loaded onto a formaldehyde gel and blotted using standard
methodology.
Total RNA was also prepared from pituitary gland, brain
cortex and skeletal muscle from sexually mature male and
female white Leghorn layer type birds. Fifteen micrograms
RNA were prepared for northern blotting according to the
method of Pelle & Murphy (1993).Tissue distribution of cGNRHR2 and quantification relative to
cGnRH-R-I
Total RNA was prepared from 3 male and 3 female,
6-week-old (pre-pubertal) Ross broiler type birds raised on
21 h light:3 h darkness and 3 male and 3 female, 24-week-oldJournal of Endocrinology (2009) 202, 179–190
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light:10 h darkness. cDNA synthesis was performed on 0.5 mg
of total RNA, using a 1st Strand Synthesis Kit (Amersham
Pharmacia Biotech Ltd). Primers that spanned exon
boundaries, 713–735f (5 0-GCTCGCTGTGCCGCAG-
CTGT-3 0; exon 2–3) and 933–952r (5 0-ACGTCCCTGG-
AGGAGAAGAG-3 0; exon 3–4) were used to amplify
cGNRHR2 from various tissue cDNA samples of the pre-
pubertal males and females (40 cycles of 95 8C/30 s,
62 8C/30 s, 72 8C/45 s). Real Time PCR was used to
quantify the mRNA expression of cGnRH-R-I and
cGNRHR2 in the pituitary gland, median eminence, small
intestine and gonad using the recommended amplification
conditions using SYBR-Green-I-dye (Invitrogen). Primers
that spanned the exon boundaries: 713–735f and 933–952r for
cGNRHR2 cDNA and primers 701–722f and 1100–1082r
for cGnRH-R-I cDNA were used with pre-pubertal and
sexually mature male and female tissue samples. Standard
curves for amplification of each GnRH receptor homologue
cDNA were made with known quantities of either chicken
GnRH receptor cDNA. The cGNRHR2 cDNA in Blue-
script II SK(C) vector and a cGnRH-R-I cDNA in Bluescript
II SK(C) vector (containing 488 bp inserted into the
EcoRV/NotI site of the vector, which corresponds to bases
1–421 of AJ304414 and 1–68 of AJ506779) were used. A linear
regression analysis of known quantities of cDNA template
versus cycle threshold values was plotted, allowing the
calculation of the quantity of target nucleic acid from
the test-sample cycle threshold values. PCR reaction with
either template reached plateau phase following the same
number of amplification cycles.Iodination of [His5-D-Tyr6]-GnRH
[His5-D-Tyr6]-GnRH-I peptide was radioactively labelled with
Iodine125 using Chloramine-T (Sigma–Aldrich) and purified
using Sephadex G25 chromatography (Sigma–Aldrich).Cell culture and gene transfection
COS-7 cells were transiently transfected by electroporation
with 10 mg expression construct. The cells were seeded in
DMEM (Sigma–Aldrich) containing a final concentration of
10% FCS, 4 mM L-glutamine and 1!penicillin/streptomycin
and incubated in a humidified atmosphere at 37 8C in
5% CO2.Figure 1 (A) Alignment of human, bullfrog, leopard gecko, African claw
representative sequences of GnRH receptor types I, II and III. Motifs in
amino acid residues are shown with dark background shading. Boxed a
helix2/helix7 micro-domain of non-mammalian GnRH receptors; 3 and 4
ligand binding residues, aspartic acid, asparagine, lysine and arginine r
indicated by a bold line. GnRH receptor subtypes are labelled accordin
(Wang et al. 2001, Ikemoto & Park 2007). (B) A phylogenetic tree based
amphibian and avian GnRH receptor sequences. The tree was constructe
Chumakov 1988).
www.endocrinology-journals.orgWhole cell radioligand binding assay
Radioligand binding assays were performed with 125I-[His5-
D-Tyr6]-GnRH-I on intact cells 48 h after transfection. Cells
were washed twice with 4 8C PBSCCa2CCMg2C (Sigma–
Aldrich). The cells were then incubated for 4 h at 4 8C with
125I-[His5-D-Tyr6]-GnRH (100 000 c.p.m./500 ml) and
various concentrations of unlabelled GnRH analogues in
25 mM DMEMCHEPESC0.1% BSA in triplicate. Cells
were then washed twice with PBSCCa2CCMg2C and lysed
with 0.1 M NaOH. Radioactivity was measured and
non-specific binding was determined by displacement of
label with 1 mM unlabelled GnRH analogue.Inositol phosphate assay
Total inositol phosphate accumulation in response to GnRH
stimulation was analysed as previously described (Berg
et al. 1994, Pawson et al. 2003) with modifications: 24 h
after transfection, cells were labelled with 1 mCi/ml per well
[3H]-myo-inositol, (Amersham Pharmacia Biotech) in 1 ml
of inositol-free DMEM (Invitrogen Life Sciences) and
incubated for a further 24 h. Cells were incubated at
37 8C with 0.5 ml 25 mM DMEMCHEPES (Sigma–
Aldrich) containing 10 mM LiCl for two successive 5 and
30 min washes prior to stimulation with GnRH analogue in
DMEMCHEPESC10 mM LiCl for 1 h. Antagonist
activity was assayed in the presence of 1 nM GnRH-II.
Stimulations were terminated by replacing medium with
10 mM formic acid and incubating at 4 8C for 1 h. Water-
soluble metabolites were separated as previously described
(Berridge et al. 1983) with a series of washes of the Dowex
resin with H2O and 60 mM ammonium formate, 5 mM
sodium tetraborate prior to inositol phosphate elution in
1 M ammonium formate, 0.1 M formic acid. Assays were
performed in triplicate.Receptor internalisation assays
Receptor-transfected cells were incubated for 48 h prior to
performing the internalisation assay as previously described
(Pawson et al. 1998). Modifications to the protocol included
addition of 0.5 ml acid solution (150 mM NaCl, 50 mM
acetic acid, pH 2.8) to determine surface bound ligand
and 0.5 ml 1 M NaOH for internalised radioligand.ed frog and chicken GnRH receptor sequences. These are
ECL3 are depicted in bold and underlined. Ubiquitously conserved
mino acids are as follows: 1 and 2, aspartic acid in the functional
, conserved coupling arginine cage motif and alanine; 5, 6, 7 and 8,
espectively. Predicted transmembrane domains (TMD1–7) are
g to the published terminology and presented in Roman numerals
on multiple sequence alignment of representative, reptilian,
d using TreeTop phylogenetic tree prediction software (Yushmanov &
Journal of Endocrinology (2009) 202, 179–190
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zero and used to normalise data. Assays were performed four
times with six replicate points per experiment.Statistical analysis
ANOVA was performed on Real time PCR data using
GenStat version 9 (VSN International Ltd, UK). Other results
were analysed using GraphPad Prism version 4.0 (GraphPad
Software, CA, USA). Non-linear regression models were
applied to the ligand binding and inositol phosphate assay
data. Receptor internalisation rates were analysed as
previously described (Pawson et al. 1998).Results
Cloning of the cGNRHR2 cDNA
We cloned a PCR cDNA product from broiler (meat-type
birds) pituitary samples that was identical to the sequence from
Gallus gallus gallus genomic DNA (ENSGALG00000020923;
Ensembl 2004) and White Leghorn strains (Genbank
AY895154). An expression construct containing the entire
coding sequence, 24 bp 5 0 to the start codon and 100 bp 30 to
the stop codon was prepared.Gene structure of cGNRHR2
Bioinformatic comparisons of the cDNA and genomic DNA
sequences confirmed that the receptor consists of a 419 amino
acid protein encoded by 4 exons (Shimizu & Bedecarrats 2006)
on chicken chromosome 10 linked to the type I receptor. The
amino acid sequence identity of the two cGnRH-Rs is 53%
(Fig. 1A). The amino acid sequences of both cGnRH-R
receptors were compared with human, bullfrog, leopard gecko
and African clawed frog GnRH receptor subtypes. The
highest homology to cGnRH-R-I was with bullfrog-II
GnRH-R. The highest homology to cGNRHR2 occurred
with bullfrog-I and leopard gecko-I GnRH-Rs. Phylogenetic
analysis performed by ourselves (Fig. 1B) and others (Flanagan
et al. 2007, Tello et al. 2008) clearly classes this receptor as a type
III GnRH receptor homologue. We therefore refer to it as
cGnRH-R-III from here on.
The putative translation start codon is coded by exon 1
and the stop codon by exon 4. The amino terminal
extracellular domain is coded by exon 1 and exon 2. Exon
2 also encodes transmembrane domain (TMD) 1, intra-
cellular loop (ICL) 1, TMD2, extracellular loop (ECL) 1,
TMD3, ICL2 and part of TMD4. Exon 3 encodes the rest of
TMD4, ECL2, TMD5 and part of ICL3. Exon 4 encodes
the rest of ICL3, TMD6, ECL3, TMD7 and the C-terminal
cytoplasmic domain (Fig. 1A).
Comparisons of functionally important residues and
micro-domains were performed. cGnRH-R-III like
cGnRH-R-I has aspartic acid in both loci of the
helix2/helix7 micro-domain, an arrangement unique toJournal of Endocrinology (2009) 202, 179–190non-mammalian GnRH receptors (Zhou et al. 1994,
Flanagan et al. 1999; Fig. 1A). Conservation of important
coupling motifs, the arginine cage motif (Ballesteros et al.
1998) and alanine in ICL3 (Myburgh et al. 1998) is
maintained in cGnRH-R-III (Fig. 1A). The two cGnRH-
Rs exhibit conservation of the aspartic acid (Flanagan et al.
2000) and asparagine (Davidson et al. 1996) ligand-binding
residues in TMD2 (Fig. 1A). The lysine in TMD3 of the
cGnRH-R-III (Zhou et al. 1995) is substituted with an
arginine residue. The glutamate residue in ECL3 (Flanagan
et al. 1994) is not conserved in cGnRH-R-III whereas it is
in cGnRH-R-I (Sun et al. 2001b). ECL3 of each receptor
type has a distinctive classification motif (Millar et al.
2004), cGnRH-R-I has a PEY motif in ECL3 whereas in
cGnRH-R-III this motif is PPS (Fig. 1A). The motifs
known to be crucial for receptor internalisation were compared
(Pawson et al. 1998, 2003), and are conserved between
cGnRH-R-I and cGnRH-R-III, however, the tail of
cGnRH-R-III is longer by an additional eight residues (Fig. 1A).Northern blot analysis
Hybridisation of cGnRH-R-III antisense oligonucleotide
probe was detected in the anterior pituitary but not testes or
small intestine RNA (Fig. 2A). The cGnRH-R-III mRNA
transcript is approximately 1600 bases long. Sense oligonu-
cleotides did not hybridise to the RNA samples (data not
shown). ACTA1 skeletal muscle 32P-dCTP labelled DNA
probe hybridised to all samples (Fig. 2B), demonstrating equal
RNA loading. A riboprobe also detected cGnRH-R-III
mRNA transcripts of approximately 1600 bases in male
and female anterior pituitary but not brain cortex or
skeletal muscle RNA (Fig. 2C). There was no evidence of
cGnRH-R-III mRNA transcript size variants in any tissues.Tissue distribution of cGnRH-R-III expression and
quantification relative to cGnRH-R-I
PCR amplification of GnRH receptor cDNA was ensured by
designing primers spanning exon boundaries. A single 238 bp
cDNA amplification product derived from exon 3 was
detected in the pituitary. Amplification of cGnRH-R-III
cDNA was detected in all tissues tested (anterior pituitary,
hind-brain, cerebrum, cerebellum, median eminence,
anterior hypothalamus, posterior hypothalamus, olfactory
bulb, optic lobe, adrenal gland, kidney, small intestine, spleen,
testes, ovary and liver) from pre-pubertal males and females
although the signal intensity in the anterior pituitary was
distinctly the highest. Relative levels of cGnRH-R-I and
cGnRH-R-III mRNA measured by real-time PCR in
juvenile and mature male and female tissues demonstrated
that expression of cGnRH-R-III was greater than cGnRH-
R-I in the pituitary, median eminence, gonads and small
intestine. In the anterior pituitary cGnRH-R-III expression
was 1373-fold that of cGnRH-R-I (Fig. 2F). Even thoughwww.endocrinology-journals.org
Figure 2 Northern blot of pituitary (P), small intestine (SI) and testes
(T) Poly (A)C RNA samples from 14-week-old AIL male birds,
hybridised with (A) cGnRH-R-III [g-32P]-dATP 5 0 end labelled
oligoprobe and (B) actin alpha skeletal muscle (ACTA1) 32P-dCTP
random primer labelled DNA probe. (C) Northern blot with pooled
male and female cortex (C), pooled male and female muscle (M) and
anterior pituitary glands (P1Zfemale, P2Zmale) total RNA samples
from white Leghorn layer type birds, hybridised with GnRH-R-III
antisense riboprobe covering all four exons. The blot shows a single
band in the pituitaries and no detectable bands in the muscle or
cortex tissues. RNA size markers were run on the original gel and
sizes were transferred to the image by interpolation. The position of
the 28S and 18S rRNA is indicated and can be seen as areas of
reduced background on the image. (D–F) Comparative quantitative
real-time PCR analysis of cGnRH-R-I and cGnRH-R-III mRNA
expression in tissues of pre-pubertal and sexually mature, male and
female broiler chickens. (D) cGnRH-R-III mRNA expression per
milligram of tissue. (E) cGnRH-R-I mRNA expression per milligram
of tissue. (F) Ratio of absolute expression of cGnRH-R-III over
cGnRH-R-I mRNA. Values are mean (mol/mg)GS.E.M., **P%0.01.
P, pituitary; ME, median eminence; SI, small intestine; T, testes; O,
ovary. (No significant differences were detected between male and
female gonads). (G) Relationship between sex and age on pituitary
cGnRH-R-III mRNA expression in pre-pubertal (nZ6) and sexually
mature (nZ6), male (nZ6; open columns) and female (nZ6; solid
columns) broiler chickens. Values are mean (mol/mg)GS.E.M.,
*P%0.05, **P%0.01.
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higher cGnRH-R-III expression was detected in the anterior
pituitary compared with the median eminence, gonads and
small intestine (Fig. 2D). Anterior pituitary expression of
cGnRH-R-III was 92.5! greater than in the testes or ovary.
Expression of cGnRH-R-I in the testes was 2-fold greater
than in the anterior pituitary (Fig. 2E).www.endocrinology-journals.orgANOVA demonstrated a significant relationship between
age and sex on pituitary cGnRH-R-III expression (Fig. 2G).
Anterior pituitary cGnRH-R-III expression was 8.4-fold
lower in sexually mature males compared with juvenile males
whereas the reciprocal relationship was observed in females,
with 2.8-fold more anterior pituitary cGnRH-R-III
expression in sexually mature females compared with
juveniles (Fig. 2G).Whole cell GnRH binding assays
Cells transfected with cGnRH-R-III and cGnRH-R-I
expression constructs showed binding and displacement of
125I-[His5-D-Tyr6]-GnRH with both cGnRH-I and
GnRH-II in a concentration dependant fashion. The bind-
ing affinities for cGnRH-I and GnRH-II were similar at
cGnRH-R-I and cGnRH-R-III (Fig. 3A). cGnRH-R-III
exhibited a 35-fold higher affinity for GnRH-II than for
cGnRH-I (Table 2). cGnRH-R-I exhibited a 21-fold
higher affinity for GnRH-II than for cGnRH-I, similar to
previous reports (Sun et al. 2001b).
cGnRH-R-III and cGnRH-R-I bound sGnRH-III and
mammalian antagonists 27, 135-18 and 135-25 (Table 2).
Because there was no genomic evidence for GnRH-III in the
chicken, the binding affinity for sGnRH-III was tested as an
alternative. cGnRH-R-III and cGnRH-R-I exhibited a
16-fold higher affinity for GnRH-II than for sGnRH-III, and
both receptors exhibited a higher affinity for sGnRH-III than
cGnRH-I (Table 2). Similar binding affinities were observed
for all GnRH analogues and mammalian antagonists at either
receptor except for mammalian antagonist 27.
cGnRH-I, GnRH-II, sGnRH-III, mammalian antagonist
135-18 and 135-25 showed respectively a 1.8, 1.1, 1.1, 3.5
and 0.6-fold higher binding affinity at cGnRH-R-I
compared with cGnRH-R-III. Remarkably, cGnRH-R-I
has a much higher affinity for mammalian antagonist 27 (Kd:
0.38 nM) than cGnRH-R-III (Kd: 21.4 nM).Inositol phosphate assays
cGnRH-I and GnRH-II stimulated inositol phosphate
production in cGnRH-R-I and cGnRH-R-III transfected
cells (Fig. 3B). The ED50 for GnRH-II was much lower than
for cGnRH-I, in accordance with their binding affinities.
GnRH-II was more potent than cGnRH-I at either receptor.
In cGnRH-R-III transfected cells, the accumulation of
inositol phosphate was six times more effective with
GnRH-II stimulation than with cGnRH-I (Table 2).
GnRH-II was four times more potent than cGnRH-I
for production of inositol phosphate via activation of
cGnRH-R-I (Table 2). The ED50 for sGnRH-III was
much higher than GnRH-II and cGnRH-I at both
cGnRH-Rs (Table 2). In response to cGnRH-I, GnRH-II
or sGnRH-III there was a 1.6, 1.1 and 2.0-fold higher
potency at cGnRH-R-I compared with cGnRH-R-III.Journal of Endocrinology (2009) 202, 179–190
Figure 3 (A) Ligand binding of cGnRH-R-I and cGnRH-R-III.
Competitive displacement of 125I-[His5-D-Tyr6]-GnRH with serial
dilutions (10K11–10K6 M) of cGnRH-I (solid squares) and
(10K11–10K6 M) GnRH-II (open squares) in COS-7 cells transiently
transfected with cGnRH-R-I (dashed lines) and cGnRH-R-III
(solid lines) expression constructs. The data presented are from four
independent experiments each performed in triplicate. Non-specific
binding, determined in un-transfected cells was subtracted
from c.p.m. (B) Inositol phosphate production in response to
(10K11–10K6 M) cGnRH-I (solid squares) and GnRH-II (open
squares) in COS-7 cells transiently transfected with cGnRH-R-I
(dashed lines) and cGnRH-R-III (solid lines) expression constructs. The
data are from four independent experiments performed in triplicate.
(C) cGnRH-R-I and cGnRH-R-III ligand induced internalisation rate.
Per cent internalisation of 125I-[His5-D-Tyr6]-GnRH ligand mediated
by cGnRH-R-I (solid triangle) and cGnRH-R-III (solid square). Data
points are the meanGS.E.M. of four independent experiments each
performed with six replicates. Non-specific binding, determined in
un-transfected cells was accounted for.
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Journal of Endocrinology (2009) 202, 179–190Mammalian antagonist 27 displayed inverse agonist
properties at either receptor, decreasing inositol phosphate
production below basal levels for both receptors (Fig. 4A
and C). Mammalian antagonist 135-25 stimulated inositol
phosphate production with very low efficacy in transfected
COS-7 cells: cGnRH-R-I (ED50: 5970 nM) and cGnRH-R-III
(ED50: 4860 nM; Table 2 and Fig. 4E and G). Mammalian
antagonist 135-18 stimulated inositol phosphate in trans-
fected COS-7 cells; cGnRH-R-III (ED50: 1510 nM) with
weak efficacy, but no stimulation of inositol phosphate was
detected in cGnRH-R-I transfected cells (Fig. 4I and K).
Inhibition of 1 nM GnRH-II-stimulated inositol phos-
phate production by mammalian antagonist 135-18 in
cGnRH-R-I transfected COS-7 cells (IC50: 2330 nM) was
more potent than for cGnRH-R-III (IC50: 3890 nM)
transfected COS-7 cells (Fig. 4J and L). Mammalian
antagonist 135-25, acted as a pure agonist in cGnRH-R-III
transfected cells in the presence of 1 nM GnRH-II, increasing
the potency of inositol phosphate stimulation from ED50:
4860 nM in the absence of GnRH-II to ED50: 20.1 nM in
the presence of GnRH-II (Fig. 4H). Antagonistic properties
for mammalian antagonist 135-25 were observed at
cGnRH-R-I (IC50: 245 nM) transfected cells, but with little
efficacy (Fig. 4F). Surprisingly, mammalian antagonist 27
exhibited large differences in antagonistic potency at
cGnRH-R-I (IC50: 2.3 nM) compared with cGnRH-R-III
(IC50: 351 nM; Fig. 4B and D).Receptor internalisation assays
The initial rate of internalisation of 125I-[His5-D-Tyr6]-
GnRH-I bound to cGnRH-R-III was slightly greater
(P!0.006) than cGnRH-R-I. cGnRH-R-I internalised at
an initial rate of 15.8%/min whereas the initial rate of
internalisation of cGnRH-R-III was determined as
26.0%/min. The per cent maximal internalisation of
cGnRH-R-I was 78.2 vs 68.9% for GnRH-R-III (Fig. 3C).Discussion
Birds, like mammals, possess two GnRH receptor subtypes in
contrast to fish, reptiles and amphibians in which three types
of receptor are generally found (Morgan & Millar 2004,
Ikemoto & Park 2007). The proximity of the two chicken
receptor subtypes on chromosome 10 (w2 Mb apart) and
their high sequence similarity, suggests they may have been
derived by gene duplication.
There has been an inclination to designate GnRH
receptors that are selective for GnRH-II as type II GnRH
receptors. However, all non-mammalian receptors, regard-
less of their structural similarity are selective for GnRH-II
(Pfleger et al. 2002). Other investigators have designated
GnRH receptors by their tissue-specific expression. This
classification is also problematic as the predominant GnRHwww.endocrinology-journals.org
Table 2 Receptor binding and peptide-stimulated inositol phosphate accumulation in response to cGnRH analogues in COS-7 cells
expressing cGnRH-R-I and cGnRH-R-III
Ligand binding IP production
cGnRH-R-I cGnRH-R-III cGnRH-R-I CGnRH-R-III
Ki (nM)
a ED50 (nM)
b IC50 (nM)
c ED50 (nM)
b IC50 (nM)
c
Analog
cGnRH-I 10.8G1.59d 19.8G3.56d 2.8G0.20d 4.38G0.18d
GnRH-II 0.51G0.07d 0.57G0.15d 0.7G0.14d 0.8G0.14d
sGnRH-III 8.40G1.21e 9.31G4.31e 10.3G4.5d 21G0.2d
27 0.38G0.09e 21.4G4.86e Inverse agoniste 2.3G0.3e Inverse agoniste 351G114e
135-18 2090G156e 7260G105e Noned 2330G134d 1510G216d 3890G2027d
135-25 14 200G1515e 8560G3402e 5970G2510d 245G207d 4860G807d Noned,f
All experiments were performed on separate occasions in triplicate.
aKi values (binding affinities) for GnRH analogues.
bED50 values for agonist activity of GnRH analogues.
cIC50 values for antagonism of IP production stimulated by 1 nM GnRH-II.
dData are meanGS.E.M. of three to four experiments.
eData are meanGS.E.M. of two to three experiments.
f20.1G8.9Zagonistic effect of peptide in presence of 1 nM GnRH-II.
Chicken type III GnRH receptor . N T JOSEPH and others 187receptor expressed in bullfrog pituitary is structurally a
type III receptor (Wang et al. 2001) while in African
clawed frog, it is a type I receptor (Troskie et al. 2000).
We therefore advocate that the receptors are grouped and
designated according to their structural and phylogenetic
relatedness. cGnRH-R-III was first designated as
cGNRHR2 (Shimizu & Bedecarrats 2006), whereas
designation as cGnRH-R-III is appropriate according to
phylogenetic classification.
Delineation of ‘cognate’ ligand/receptor pairing requires
the demonstration of receptor protein expression in the
target cell and demonstration of ligand isoform delivery to
that cell. In the chicken there is good evidence (Mikami et al.
1988, Sharp et al. 1990, Vangils et al. 1993) that cGnRH-I
targets the gonadotroph and the higher expression levels
of GnRH-R-III in the pituitary suggest that it is the
cognate pituitary receptor. Expression of cGnRH-R-III
was 1373-fold higher than cGnRH-R-I in the anterior
pituitary gland. However, GnRH-R-III localisation to
the gonadotroph remains to be demonstrated. Therefore,
the development of analogues that differentially promote or
inhibit activation of receptor subtypes may be valuable tools
for deciphering the role of receptor types in terms of
gonadotrophin regulation or other putative functions.
No sex differences or changes in expression were detected
for cGnRH-R-I, however, a pronounced reciprocal sex
difference in pituitary cGnRH-R-III expression was
observed. Higher cGnRH-R-III mRNA levels occur in
adult females compared with adult males. In contrast, in
juvenile chickens, higher cGnRH-R-III mRNA levels
occurred in males compared with females. cGnRH-R-III
splice variant transcripts detected by PCR amplification
(Shimizu & Bedecarrats 2006) were not detected by
oligonucleotide probe or riboprobe using northern blotting,www.endocrinology-journals.orgsuggesting that their in vivo expression is relatively low and
may be of little functional significance.
Differences in cGnRH-R-III receptor expression levels
between juvenile and mature males and females were not
reported previously (Shimizu & Bedecarrats 2006). This may
be due to the age of animals used in different studies. The
sexual dimorphism in cGnRH-R-III expression, where levels
of mRNA are higher in juvenile males compared with
juvenile females, is consistent with the LH response to photo-
stimulation seen in juveniles, where there is a robust response
in males but not in females (Sreekumar & Sharp 1998).
However, in adult males and females, cGnRH-R-III
expression levels are inversely related to sex differences in
LH responsiveness to GnRH injection (Sharp et al. 1987).
When chicken pituitary fragments from adult males and
juveniles of both sexes are perifused, a large spike followed by
a plateau in LH release in response to GnRH stimulation is
observed (Liu et al. 1995). Adult laying hens do not exhibit
the rapid spike of release but do show the plateau phase and
the release of LH in adult hens is much reduced compared
with juvenile hens (Liu et al. 1995). In general, our
observations suggest that the level of GnRH-R-III mRNA
may be inversely related to the release of LH by gonadotrophs
in adult females. There are several possible explanations for
this apparent paradox. However, cGnRH-R-III mRNA may
be reflective of expression of membrane cGnRH-R-III
receptor number, but that increased ovarian steroid and
peptide hormones act negatively in the adult female to
diminish the LH response to GnRH at the gonadotroph,
through down-regulation of intercellular signalling pathways
including the Ca2Cmobilisation mechanism (Liu et al. 1995).
As noted above, the occurrence of two or three forms of
GnRH peptide hormone in different vertebrate species
initially suggested the existence of different cognate receptorsJournal of Endocrinology (2009) 202, 179–190
Figure 4 Inositol phosphate production in response to (10K10–
10K5 M) mammalian antagonist 27 (A and C); 135-25 (E and G) and
135-18 (I and K) in COS-7 cells transiently transfected with cGnRH-
R-I (filled squares (A, E and I)) and cGnRH-R-III (open squares (C, G
and K)). The ability to inhibit inositol phosphate formation by
mammalian antagonist 27 (B and D); 135-25 (F and H) and 135-18
( J and L) in the presence of 1 nM GnRH-II stimulation was
measured in COS-7 transiently transfected with cGnRH-R-I
(filled circles (B)) and cGnRH-R-III (open circles (D)). Inositol
phosphate production in response to 10K8 M GnRH-II stimulation
(asterisks). Non-stimulated basal inositol phosphate accumulation
(diamonds). The data are the meanGS.E.M. of three independent
experiments performed in triplicate.
N T JOSEPH and others . Chicken type III GnRH receptor188able to differentially recognise the different ligands.
Selectivity for GnRH-II is emerging as a general phenom-
enon for non-mammalian GnRH receptors due to the
preconfigured b-II 0 turn of GnRH-II (Pfleger et al. 2002).
The current study supports this concept in that bothJournal of Endocrinology (2009) 202, 179–190cGnRH-Rs maintain higher ligand selectivity for GnRH-II.
This presents a conundrum in that cGnRH-I is the
hypothalamic peptide regulating the gonadotroph (Mikami
et al. 1988, Sharp et al. 1990). GnRH-II was more potent
at stimulating inositol phosphate production at the
cGnRH-R-III than cGnRH-I. Similarly, GnRH-II stimu-
lates inositol phosphate production four times more potently
at cGnRH-R-I than cGnRH-I, consistent with previous
data (Sun et al. 2001b, Shimizu & Bedecarrats 2006). Since
inositol phosphate and diacyl-glycerol are generated by the
recruitment of the Gq protein and activation of PLC-b
(Stojilkovic et al. 1994, Ruf et al. 2003), cGnRH-R-III can
activate the protein kinase C and Ca2C second messenger
signalling pathways, which are the predominant mediators of
LH and FSH biosynthesis and secretion (Conn & Crowley
1994, Sealfon et al. 1997). However, receptor ligand
selectivity measured in vitro does not necessarily correlate
with in vivo functional significance nor does it determine the
designation of cognate receptors. Maybe evolutionary
recruitment of ligand–receptor pairing for particular
physiological processes is not determined by selection
according to the highest affinity for ligand binding or
efficacy in inositol phosphate production.
Considering differences between the two chicken
receptors, the possibility that cGnRH-R-III may differ
from cGnRH-R-I in the rate of ligand-induced internal-
isation was anticipated because eight additional residues
occur in the carboxyl-terminal tail of cGnRH-R-III, a
domain that predisposes GnRH-Rs to rapid rates of
internalisation (Pawson et al. 1998). A slightly greater rate
of internalisation was measured for cGnRH-R-III compared
with cGnRH-R-I. The region crucial for receptor
internalisation of cGnRH-R-I is distal residue 336 in
cGnRH-R-I (Pawson et al. 1998). In cGnRH-R-III, this
region contains all eight of the additional residues that
comprise the elongated tail. The spatial arrangement of
amino acid residues in the carboxyl-terminus region of
cGnRH-R-III may contribute to the increase in internal-
isation rate, given that the known residues important for
internalisation are conserved between the two receptors
(Pawson et al. 1998, 2003; Fig. 1A).
Both cGnRH-R-III and cGnRH-R-I have a significantly
higher binding affinity for mammalian antagonist 27
compared with mammalian antagonists 135-18 and 135-25.
GnRH-R-I showed a 56-fold higher binding affinity for
antagonist 27 than the binding affinity at cGnRH-R-III. The
observed low binding affinities of mammalian antagonists
135-25 and 135-18 are translated into similarly low potencies
in their capacity to stimulate or inhibit inositol phosphate
accumulation. The sizes of these effects are too small to
accurately differentiate the two receptor subtypes.
Antagonist 27 showed inverse agonistic effects at both
chicken receptors. Differences in binding affinity were
translated into differences in antagonistic effects at the
receptors, with antagonist 27 showing a 153-fold higher
antagonistic effect at cGnRH-R-I than cGnRH-R-III.www.endocrinology-journals.org
Chicken type III GnRH receptor . N T JOSEPH and others 189Therefore, it may be possible to utilise antagonist 27 to
differentially block type I GnRH receptor function in vivo in
order to study type III GnRH receptor physiology.
In summary, we directly compared pharmacological
properties of cGnRH-R-I and cGnRH-R-III, and found
both receptors to be similar in response to endogenous
chicken GnRH ligands. Pharmacological profiling of the
type I and type III GnRH receptors has established that
GnRH-II is more selective and more potent in inositol
phosphate accumulation at both receptors than cGnRH-I.
cGnRH-R-III has a more rapid internalisation rate than
cGnRH-R-I. Activation and inhibition by GnRH analogues
acting on cGnRH-R-I and cGnRH-R-III has been
characterised using a range ligands (sGnRH-III, mammalian
antagonist 27, 135-18 and 135-25), furthering the pharma-
cological profile of both receptor subtypes.
The findings concerning ligand selectivity, G protein
coupling and internalisation of cGnRH-R-III suggest that it
could theoretically function similarly to cGnRH-R-I to
regulate gonadotrophin synthesis. However, the predominant
levels of cGnRH-R-III mRNA in the pituitary gland (1373-
fold more than cGnRH-R-I), and the changes in expression
patterns with age and sex suggest a distinct functional capacity
of cGnRH-R-III compared with cGnRH-R-I.
However, further experiments are required to elucidate the
role of cGnRH-R-III within the pituitary. Our studies
suggest that evolutionary plasticity in the tissue-specific
adoption of GnRH ligand and receptor subtypes for
regulation of particular physiological functions may have
occurred in birds. Birds appear to have adopted a strategy to
regulate gonadotrophin synthesis and release, which utilises
cGnRH-I and cGnRH-R-III pairing. The development of
GnRH analogues such as antagonist 27 that differentially
affect GnRH receptor subtype function will be valuable for
determining the physiological roles of different ligands and
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